Our vision:To make a significant contribution to human and animal health by establishing the ISCOM technology as a first choice adjuvant platform for human and animal vaccines.

Isconova is a well-established, forward-looking company committed to driving the development of its proprietary Immune Stimulating Complex (ISCOM) adjuvant technology. The Immune Stimulating Complex (ISCOM) technology induces a strong, long-lasting immunological response and is used, for example, by vaccine producers to create and manufacture highly effective and safe vaccines. The company and its collaboration partners have a strong veterinary focus.

Isconova is headquartered at Uppsala Science Park in the heart of Sweden’s largest biotechnology cluster. It maintains an excellent relationship with local universities and cooperates actively on research programs and development projects.

The company enjoys all the benefits of modern facilities. Research and development laboratories are located side-by-side with production, which ensures a smooth and cost-effective transition to finished product, especially for special orders. Over the years, Isconova has built-up a vast bank of product and application know-how. Qualified technical support is always close at hand.

Isconova provides your company with an outstanding adjuvant technology platform

We have extensive experience of adjuvant platforms for vaccine development and production. Our research team cooperates closely with vaccine developers to create ever better products and antigen delivery systems. In supplying both small and large quantities of adjuvants, we can support your next vaccine program all the way from vaccine development to full-scale commercial production. See Licensing Opportunities for more information.

Large-scale production capacity

All product manufacture takes place in-house under closely monitored conditions, and is followed by stringent quality control. We have the production capacity to supply bulk quantities of standard and custom adjuvants on request.

AbISCO® research adjuvants for effective immune responses

Using our proprietary adjuvant platform, we develop, manufacture and sell ready-made AbISCO® adjuvants for creating highly-effective antigen delivery systems that facilitate antibody production and animal immune response studies. We deliver directly to users worldwide. Special products can also be developed and supplied.